Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

PROCOVAXED: Promoting COVID vaccination in emergency departments

Researchers examine the reasons behind COVID-19 vaccine hesitancy emergency department patients when educated through vaccine messaging platforms.

22 Mar 2022

Rubella antibodies vs. COVID-19

A new study describes a potential relationship between antibody titers against the rubella virus and the severity of COVID-19.

22 Mar 2022

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

Scientists have worked extensively hard to contain the COVID-19 pandemic caused by the rapid transmission of SARS-CoV-2.

22 Mar 2022

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Researchers have determined the effect of booster immunization on the levels of antibodies generated, against SARS-CoV-2 variants, including the Omicron strain, in cancer patients with or without active B cell-targeted therapy.

22 Mar 2022

Study evaluates the effectiveness of lactobacilli throat sprays against COVID-19

A recent study evaluated the effectiveness of lactobacilli throat sprays against COVID-19.

22 Mar 2022

Maternal and infant antibody levels and transplacental transfer following SARS-CoV-2 infection and vaccination

A recent study evaluated maternal antibody responses against SARS-CoV-2 and transplacental transfer.

22 Mar 2022

How valid are the reported results on health outcomes in children after acute SARS-CoV-2 infection?

Researchers discussed the validity of reported health outcomes post-acute infection with SARS-CoV-2 in children.

22 Mar 2022

SARS-CoV-2 nanobody that binds to the receptor-binding domain could prevent COVID-19 in animals

A new study assessed the potential of a nanobody – directly prepared by binding to SARS-CoV-2 spike receptor-binding domain protein, in the treatment of COVID-19.

22 Mar 2022

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Researchers presented a systematic analysis of the affinity and conformational dynamics between the binding of SARS-CoV-2 receptor-binding domain spike protein and the host angiotensin-converting enzyme 2 receptor.

22 Mar 2022

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Researchers discussed patient features, treatment-associated process measures, and outcomes associated with early monoclonal antibody and antiviral therapy in high-risk pediatric patients infected with the SARS-CoV-2 Omicron variant.

22 Mar 2022

Researchers study COVID-19-associated loss of life expectancy among Native Americans

Researchers assessed the loss in life expectancy in the Native American population during 2020 and 2021 due to COVID-19.

22 Mar 2022

Length of stay distributions of hospitalized COVID-19 cases during a mixed Omicron-Delta epidemic in Australia

Researchers determined the hospital stay lengths for COVID-19 patients infected by the Omicron and Delta variants of SARS-CoV-2.

22 Mar 2022

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Researchers performed an in situ analysis to evaluate the correlation between CD48 expression and COVID-19.

22 Mar 2022

Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

A new study investigated the interactions between SARS-CoV-2 proteins and viral and host ribonucleic acid in virus-infected cells.

22 Mar 2022

The effect of the COVID-19 vaccination campaign on 250 cities in Israel

A recent study assessed the impact of COVID-19 vaccines on unvaccinated populations and analyzed the various vaccination policies in Israel.

22 Mar 2022

Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

Researchers evaluated the importance of the Ex3Lx6L motif in SARS-CoV-2 entry into host cells mediated by the spike protein syncytium formation and membrane fusion.

22 Mar 2022

Study explores minimal classroom transmission of COVID-19 in a large urban university

A new study investigated the extent of SARS-CoV-2 transmission in classrooms of a large urban university.

22 Mar 2022

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

Researchers reported a hybrid approach comprising computational models and high throughput screening to discover allosteric ACE2 binders inhibiting viral replication without interrupting ACE2 renal, pulmonary, immune, and cardiovascular functions.

22 Mar 2022

Waning antibody responses in SARS-CoV-2-infected or vaccinated population

A recent study posted to the bioRxiv* preprint server evaluated the effects of the waning of antibodies after coronavirus disease 2019 (COVID-19) infection or vaccination.

22 Mar 2022

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

In a recent study posted to the bioRxiv* preprint server, researchers conducted a phylogenetic investigation of the human parainfluenza type 3 virus strain (HPIV3) that caused an outbreak in South Korea amid the coronavirus disease 2019 (COVID-19) pandemic.

22 Mar 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

PROCOVAXED: Promoting COVID vaccination in emergency departments

Rubella antibodies vs. COVID-19

The relative performance of OPS, NPS, and saliva for detecting the Delta and Omicron SARS-CoV-2 variants

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Study evaluates the effectiveness of lactobacilli throat sprays against COVID-19

Maternal and infant antibody levels and transplacental transfer following SARS-CoV-2 infection and vaccination

How valid are the reported results on health outcomes in children after acute SARS-CoV-2 infection?

SARS-CoV-2 nanobody that binds to the receptor-binding domain could prevent COVID-19 in animals

Molecular dynamic simulations unveil conformational dynamics of SARS-CoV-2 spike protein RBD and ACE2 receptor

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Researchers study COVID-19-associated loss of life expectancy among Native Americans

Length of stay distributions of hospitalized COVID-19 cases during a mixed Omicron-Delta epidemic in Australia

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

The effect of the COVID-19 vaccination campaign on 250 cities in Israel

Posaconazole found to be effective as a small molecule fusion inhibitor against SARS-CoV-2 variants

Study explores minimal classroom transmission of COVID-19 in a large urban university

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

Waning antibody responses in SARS-CoV-2-infected or vaccinated population

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in